Intraperitoneal alpha therapy with (224)Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model

A novel alpha-therapy consisting of (224)Ra-labeled calcium carbonate microparticles ((224)Ra-CaCO(3)-MP) has been designed to treat micrometastatic peritoneal disease via intraperitoneal (IP) administration. This preclinical study aimed to evaluate its efficacy and tolerability when given as a sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wouters, Roxanne, Westrøm, Sara, Berckmans, Yani, Riva, Matteo, Ceusters, Jolien, Bønsdorff, Tina B., Vergote, Ignace, Coosemans, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588927/
https://www.ncbi.nlm.nih.gov/pubmed/36300186
http://dx.doi.org/10.3389/fmed.2022.995325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588927/
https://www.ncbi.nlm.nih.gov/pubmed/36300186
http://dx.doi.org/10.3389/fmed.2022.995325

Ejemplares similares